A detailed history of Harbour Trust & Investment Management CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Harbour Trust & Investment Management CO holds 18,931 shares of ABBV stock, worth $3.39 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
18,931
Previous 19,419 2.51%
Holding current value
$3.39 Million
Previous $3.33 Billion 12.24%
% of portfolio
0.43%
Previous 0.4%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$163.84 - $199.33 $79,953 - $97,273
-488 Reduced 2.51%
18,931 $3.74 Billion
Q2 2024

Jul 23, 2024

SELL
$154.79 - $180.76 $77,085 - $90,018
-498 Reduced 2.5%
19,419 $3.33 Billion
Q1 2024

Apr 22, 2024

SELL
$159.82 - $182.1 $38,676 - $44,068
-242 Reduced 1.2%
19,917 $3.63 Billion
Q4 2023

Jan 26, 2024

BUY
$137.6 - $154.97 $2.77 Million - $3.12 Million
20,159 New
20,159 $3.12 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Harbour Trust & Investment Management CO Portfolio

Follow Harbour Trust & Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Trust & Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Trust & Investment Management CO with notifications on news.